Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer

被引：0
作者：
Aydan Eroglu
Ragip Çam
Yonca Eğin
Nejat Akar
机构：
[1] Ankara University Medical School,Department of General Surgery
[2] Ankara University Medical School,Department of Pediatric Molecular Genetic
来源：
Breast Cancer Research and Treatment | 2009年 / 116卷
关键词：
Breast Cancer; Disease Free Survival; Thrombophilia; Disease Free Survival Rate; G20210A Polymorphism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：619 / 620
页数：1
相关论文
共 40 条
  • [1] Winter PC(2006)The pathogenesis of venous thromboembolism in cancer: emerging links with tumor biology Hematol Oncol 24 126-133
  • [2] Paspatis GA(2002)Resistance to activated protein C, factor V Leiden and prothrombin G20210A variant in patients with colorectal cancer Pathophysiol Haemost Thromb 32 2-7
  • [3] Sfyridaki A(2004)Hypercoagulable states in patients with hepatocellular carcinoma Dig Dis Sci 49 854-858
  • [4] Papanikolaou N(2005)Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25 2561-2565
  • [5] Triantafyllou K(2006)Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer World J Gastroenterol 12 4179-4180
  • [6] Livadiotaki A(2002)Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma Cancer 94 3120-3126
  • [7] Kapsoritakis A(2007)Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation J Cell Mol Med 11 561-568
  • [8] Samonakis DN(2007)Prevalence of factor V 1691G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients J Thromb Thrombolysis 23 31-34
  • [9] Koutroubakis IE(undefined)undefined undefined undefined undefined-undefined
  • [10] Sfiridaki A(undefined)undefined undefined undefined undefined-undefined
1234